Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, you can change the day you take Wegovy. Because semaglutide stays active in your body for roughly a week after each injection, shifting your injection day is possible as long as at least four days separate your last dose from the new one. Your prescriber should confirm the plan before you make any change. As a prescription-only medicine, Wegovy requires clinical oversight — including any adjustments to how you time your doses — so this is not something to decide alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide, the active ingredient in Wegovy, works by mimicking the GLP-1 gut hormone, slowing gastric emptying, dampening appetite signals and influencing blood-sugar regulation. It builds up gradually in your system over the first few weeks of treatment, and each injection is designed to sustain that level across seven days. That week-long activity window is precisely why a single missed day does not undo everything, but it is also why spacing matters: doses taken too close together can stack the drug's concentration higher than intended, making gastrointestinal side effects (nausea, vomiting, loose stools) noticeably worse. The NHS semaglutide information page reinforces that consistent weekly timing is the baseline expectation for this medicine.
Routine helps more than people expect. Many patients anchor their injection to something that happens once a week without fail, Sunday evening after the shopping, or Monday morning before the kettle has finished boiling. If that anchor stops working for you, a deliberate, one-off adjustment is far safer than drifting to a different day each week.
It is safe when done correctly. The key rule is a minimum four-day gap between the dose you took on the old day and the first dose on your newly chosen day. So if you have been injecting every Thursday and want to move to Monday, you would wait until the following Monday, provided at least four clear days have passed since Thursday's injection. That single Monday injection then sets the new weekly rhythm going forward.
What you must not do is inject on both the old day and the new day in the same week to avoid feeling like you missed one. Doubling up is not how a day-change works, and bringing two doses within a few days of each other risks a sharp rise in side effects. If you are mid-titration (still working through the 0.25 mg, 0.5 mg, 1.0 mg, or 1.7 mg steps on the way to the 2.4 mg maintenance dose) flag the change to your prescriber before you act. Timing precision matters more during titration. Some patients considering a permanent switch find it helpful to read about how to change their Wegovy day in more detail before deciding.
One practical note on storage: Wegovy pens live in the fridge, so wherever your pen is kept matters to routine. If your pen lives in the door of the fridge and you inject Friday evenings after work, moving to a Saturday-morning routine requires remembering the pen is still cold from the night before, a small thing, but worth thinking through when you set up the new pattern.
If you miss a dose altogether (not as a planned day-change but through forgetting) the guidance is to inject as soon as you remember, provided your next scheduled dose is still at least four days away. If fewer than four days remain before your next dose is due, skip the missed one and continue on your usual schedule. Never take two injections to compensate. This is the same four-day rule that governs a planned day-change, which is why the two situations often get conflated.
A genuine planned day-change is a one-time, deliberate adjustment with a new weekly schedule set from that point on. An accidental missed dose followed by a late injection is a one-off correction that does not move your schedule permanently. The distinction matters: if you consistently find your current injection day hard to stick to, that is worth raising with your prescriber as a planned change rather than managing week to week through late doses. Our Wegovy treatment overview covers how consistency across the full titration period shapes the results you can expect. You can also find broader information about how semaglutide works as the active medicine across both weekly injections and, now, daily tablets.
If you have any doubt about how to handle a missed dose or a planned switch, the Patient Information Leaflet inside your pen box is the definitive reference, or speak directly with your prescriber before making any change. Wegovy is a prescription medicine assessed and supplied under clinical oversight; that oversight does not stop at the first injection. The NHS England weight-management injections guidance is clear that ongoing clinical review is part of how this treatment is meant to work. If you are thinking about whether Wegovy is still the right medicine for your situation, it is also worth knowing that some patients explore switching to Wegovy from another treatment, and that can also be discussed at a clinical review. For questions about how this medicine may affect other aspects of your health, such as changes to your menstrual cycle, or even shifts in taste perception, those are all worth raising with a prescriber too. When you are ready to talk through your treatment, you can speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.